Sign in

CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company

Foghorn Therapeutics Inc.

Sign in to watch
Ticker
FHTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-586-3100
Business address
500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
  1. 8-K Event Regulation FD disclosure · Other events
  2. SC 13G/A Stake Amended Statement of Ownership
  3. 4 Planned sale Chief People Officer sold 36,613 shares at an average $10.04 ($367,706)
  4. SC 13G Stake Amended Statement of Ownership
  5. 4 Planned sale Chief People Officer sold 11,574 shares at $10.05 ($116,319)
  6. 4 Planned sale Chief People Officer sold 10,672 shares at an average $10.04 ($107,131)
  7. 144 Insider Sale of Securities
  8. 4 Planned sale Chief Scientific Officer sold 20,000 shares at $9.50 ($190,000)
  9. 144 Insider Sale of Securities
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 424B5 Offering Prospectus
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations · Regulation FD disclosure
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 18 · 356 filings